TAVELLA, KETTY
Distribuzione geografica
Continente | # |
---|---|
NA - Nord America | 193 |
EU - Europa | 85 |
AS - Asia | 29 |
OC - Oceania | 4 |
AF - Africa | 1 |
SA - Sud America | 1 |
Totale | 313 |
Nazione | # |
---|---|
US - Stati Uniti d'America | 191 |
IT - Italia | 31 |
PL - Polonia | 12 |
VN - Vietnam | 10 |
CZ - Repubblica Ceca | 9 |
IE - Irlanda | 9 |
FR - Francia | 8 |
RU - Federazione Russa | 7 |
AU - Australia | 4 |
NL - Olanda | 4 |
HK - Hong Kong | 3 |
IL - Israele | 3 |
SG - Singapore | 3 |
CA - Canada | 2 |
CN - Cina | 2 |
IN - India | 2 |
MY - Malesia | 2 |
PK - Pakistan | 2 |
BR - Brasile | 1 |
DE - Germania | 1 |
ES - Italia | 1 |
FI - Finlandia | 1 |
GB - Regno Unito | 1 |
JP - Giappone | 1 |
KR - Corea | 1 |
UA - Ucraina | 1 |
ZA - Sudafrica | 1 |
Totale | 313 |
Città | # |
---|---|
Fairfield | 31 |
Santa Cruz | 26 |
Ashburn | 14 |
Buffalo | 13 |
Florence | 12 |
Warsaw | 12 |
Houston | 11 |
Seattle | 11 |
Woodbridge | 10 |
Dublin | 9 |
Wilmington | 7 |
Dong Ket | 6 |
Hanoi | 4 |
Milan | 4 |
Cambridge | 3 |
Central | 3 |
Chicago | 2 |
Clearwater | 2 |
Council Bluffs | 2 |
Dallas | 2 |
Las Vegas | 2 |
Milpitas | 2 |
Mountain View | 2 |
Pratovecchio | 2 |
Rome | 2 |
San Jose | 2 |
Singapore | 2 |
Tel Aviv | 2 |
Amsterdam | 1 |
Andover | 1 |
Ann Arbor | 1 |
Auburn | 1 |
Barcelona | 1 |
Cedar Knolls | 1 |
Cormano | 1 |
Crugers | 1 |
Gangnam-gu | 1 |
George Town | 1 |
Hadera | 1 |
Henderson | 1 |
Indore | 1 |
Jacksonville | 1 |
Jersey City | 1 |
Kuala Lumpur | 1 |
Los Angeles | 1 |
Muizenberg | 1 |
Murwara | 1 |
Nuremberg | 1 |
Ottawa | 1 |
Phoenix | 1 |
Ragusa | 1 |
Recife | 1 |
Riva | 1 |
San Diego | 1 |
San Felice A Cancello | 1 |
Shanghai | 1 |
Southend | 1 |
Sunshine | 1 |
Tampere | 1 |
Toronto | 1 |
Verona | 1 |
Washington | 1 |
Totale | 234 |
Nome | # |
---|---|
Expression of FGD3 gene as prognostic factor in young breast cancer patients, file e398c37f-c98d-179a-e053-3705fe0a4cff | 110 |
Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer., file e398c378-fb7c-179a-e053-3705fe0a4cff | 101 |
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors, file e398c37f-f10b-179a-e053-3705fe0a4cff | 62 |
Evolution of Adjuvant Chemotherapy for Breast Cancer: Review of Our Experience with Three Chemotherapy Regimens and Trastuzumab, Between 2000 and 2017, file e398c37e-b030-179a-e053-3705fe0a4cff | 46 |
Prognostic Role of Tumor Size Reduction >50% after Neoadjuvant Chemotherapy for Breast Cancer, file 9828fbae-da9e-4533-9360-ef8a7e9ab150 | 12 |
Totale | 331 |
Categoria | # |
---|---|
all - tutte | 840 |
article - articoli | 0 |
book - libri | 0 |
conference - conferenze | 0 |
curatela - curatele | 0 |
other - altro | 0 |
patent - brevetti | 0 |
selected - selezionate | 0 |
volume - volumi | 0 |
Totale | 840 |
Totale | Lug | Ago | Sett | Ott | Nov | Dic | Gen | Feb | Mar | Apr | Mag | Giu | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018/2019 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 4 | 5 |
2019/2020 | 46 | 10 | 11 | 0 | 4 | 3 | 2 | 2 | 3 | 3 | 2 | 3 | 3 |
2020/2021 | 66 | 6 | 9 | 4 | 5 | 6 | 4 | 0 | 4 | 4 | 15 | 4 | 5 |
2021/2022 | 84 | 9 | 3 | 6 | 3 | 6 | 1 | 6 | 1 | 4 | 8 | 27 | 10 |
2022/2023 | 71 | 5 | 3 | 19 | 14 | 3 | 4 | 8 | 1 | 1 | 8 | 1 | 4 |
2023/2024 | 45 | 0 | 4 | 9 | 5 | 7 | 1 | 6 | 9 | 1 | 3 | 0 | 0 |
Totale | 331 |